Toxicologie > Valeurs de référence > Autres valeurs des organismes reconnus
Last update the 05/07/2021| Target | Exposure route | Effect type | Exposure type | Value name | Value | Source | Commentary | Critical effect retained | Status state | Exposure duration | Environment | Exposure source | Factor | Management context | Age dependent adjustments factors | ADAF - Age range | ADAF - Value | ADAF - URL |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Population générale | Inhalation | A seuil | Aiguë | MRL | 2 ppm | ATSDR (2012) | Ocular | Final | Air ambiant | |||||||||
| Population générale | Inhalation | A seuil | Chronique | MRL | 0,03 ppm | ATSDR (2012) | Resp. | Final | Air ambiant | |||||||||
| Population générale | Inhalation | A seuil | Sub-chronique | MRL | 0,2 ppm | ATSDR (2012) | Resp. | Final | Air ambiant | |||||||||
| Population générale | Orale | A seuil | Aiguë | MRL | 5 mg.kg-1.j-1 | ATSDR (2012) | Develop. | Final | Eau | |||||||||
| Population générale | Orale | A seuil | Chronique | MRL | 0,1 mg.kg-1.j-1 | ATSDR (2012) | Hepatic | Final | Eau | |||||||||
| Population générale | Orale | A seuil | Sub-chronique | MRL | 0,5 mg.kg-1.j-1 | ATSDR (2012) | Hepatic | Final | Eau | |||||||||
| Population générale | Inhalation | A seuil | Aiguë | REL | 3000 µg.m-3 | OEHHA (2008) | Nasal and eye irritation in healthy human volunteers | Final | Air ambiant | |||||||||
| Population générale | Inhalation | A seuil | Chronique | RfC | 0,03 mg.m-3 | US EPA (2013) | Atrophy and respiratory metaplasia of the olfactory epithelium | Final | Air ambiant | |||||||||
| Population générale | Inhalation | A seuil | Chronique | REL | 3000 µg.m-3 | OEHHA (2002) | Liver, kidney, hematologic changes in rats | Final | Air ambiant | |||||||||
| Population générale | Inhalation | Sans seuil | Chronique | Inhalation Unit Risk | 0,000005 (µg.m-3)-1 | US EPA (2013) | Multiple (nasal, liver, kidney, peritoneal, mammary gland, and Zymbal gland) | Final | Air ambiant | |||||||||
| Population générale | Inhalation | Sans seuil | Chronique | Inhalation Unit Risk | 0,0000077 (µg.m-3)-1 | OEHHA (1999) | hepatocarcinomas or adenomas | Final | Air ambiant | |||||||||
| Population générale | Orale | A seuil | Chronique | RfD | 0,03 mg.kg-1.j-1 | US EPA (2010) | Liver and kidney toxicity | Final | Eau | |||||||||
| Population générale | Orale | Sans seuil | Chronique | Oral Slope Factor | 0,1 (mg.kg-1.j-1)-1 | US EPA (2013) | Hepatocellular adenoma and carcinoma | Final | Eau | |||||||||
| Population générale | Orale | Sans seuil | Chronique | TDI | 16 µg.kg-1.j-1 | OMS (2022) | hepatocellular tumours | Final | Eau |